Ouro Fino Saúde Animal Participações S.A.

BOVESPA:OFSA3 Stock Report

Market Cap: R$1.0b

Ouro Fino Saúde Animal Participações Past Earnings Performance

Past criteria checks 0/6

Ouro Fino Saúde Animal Participações's earnings have been declining at an average annual rate of -10.1%, while the Pharmaceuticals industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 11.9% per year.

Key information

-10.1%

Earnings growth rate

-10.1%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate11.9%
Return on equity-4.8%
Net Margin-3.5%
Next Earnings Update08 Aug 2024

Recent past performance updates

Recent updates

One Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Analyst Just Cut Their EPS Forecasts

May 19
One Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Analyst Just Cut Their EPS Forecasts

Is Ouro Fino Saúde Animal Participações (BVMF:OFSA3) A Risky Investment?

Dec 20
Is Ouro Fino Saúde Animal Participações (BVMF:OFSA3) A Risky Investment?

These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well

Jul 28
These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well

We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Can Stay On Top Of Its Debt

Feb 01
We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Can Stay On Top Of Its Debt

Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Has A Pretty Healthy Balance Sheet

May 27
Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Has A Pretty Healthy Balance Sheet

Is Now The Time To Put Ouro Fino Saúde Animal Participações (BVMF:OFSA3) On Your Watchlist?

Mar 01
Is Now The Time To Put Ouro Fino Saúde Animal Participações (BVMF:OFSA3) On Your Watchlist?

Does Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Have A Healthy Balance Sheet?

Feb 08
Does Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Have A Healthy Balance Sheet?

Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Jan 21
Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Growing Earnings But Are They A Good Guide?

Jan 03
Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Growing Earnings But Are They A Good Guide?

Introducing Ouro Fino Saúde Animal Participações (BVMF:OFSA3), A Stock That Climbed 42% In The Last Three Years

Dec 15
Introducing Ouro Fino Saúde Animal Participações (BVMF:OFSA3), A Stock That Climbed 42% In The Last Three Years

Should You Be Adding Ouro Fino Saúde Animal Participações (BVMF:OFSA3) To Your Watchlist Today?

Nov 27
Should You Be Adding Ouro Fino Saúde Animal Participações (BVMF:OFSA3) To Your Watchlist Today?

What You Can Learn From Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) P/E

Aug 09
What You Can Learn From Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) P/E

We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Taking Some Risk With Its Debt

Jul 13
We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Taking Some Risk With Its Debt

Revenue & Expenses Breakdown

How Ouro Fino Saúde Animal Participações makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BOVESPA:OFSA3 Revenue, expenses and earnings (BRL Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24954-3426955
31 Dec 23943-5027460
30 Sep 23985-2328563
30 Jun 231,0021728868
31 Mar 231,00611128869
31 Dec 221,04113128469
30 Sep 2298912227267
30 Jun 2294311226465
31 Mar 2293912025263
31 Dec 2190511424459
30 Sep 2185510824052
30 Jun 2184511923347
31 Mar 2178710122543
31 Dec 207309021740
30 Sep 207068318856
30 Jun 206355019046
31 Mar 206405020436
31 Dec 196204620828
30 Sep 19598402350
30 Jun 19604502310
31 Mar 19588602210
31 Dec 18589692170
30 Sep 18576722050
30 Jun 18546601970
31 Mar 18522491950
31 Dec 17505381960
30 Sep 1744231960
30 Jun 1743702020
31 Mar 17434-92100
31 Dec 16457-52150
30 Sep 16523312170
30 Jun 16547442180
31 Mar 16545582100
31 Dec 15534692020
30 Sep 15580612450
30 Jun 15459501970
31 Mar 15414461740
31 Dec 14402431720
31 Dec 13384541680

Quality Earnings: OFSA3 is currently unprofitable.

Growing Profit Margin: OFSA3 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OFSA3 is unprofitable, and losses have increased over the past 5 years at a rate of 10.1% per year.

Accelerating Growth: Unable to compare OFSA3's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OFSA3 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (5.7%).


Return on Equity

High ROE: OFSA3 has a negative Return on Equity (-4.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.